EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Toxic Retrosternal Goiter Treated with Radioiodine: A Case Report

Miriam N.Y. Yartey, Alfred O. Ankrah

World Journal of Nuclear Medicine · 01.06.2023 · 22 (02) · 152-170

DOI: 10.1055/s-0043-1769986 ↗

Kurz gefasst

Fallbericht in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.06.2023. Verfasst von Miriam N.Y. Yartey und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ankrah.alfred@gmail.com Introduction: Hyperthyroidism may be treated with antithyroid medications, surgery, or radioiodine. Surgery and radioiodine are the more definitive treatments. Patients with enlarged goiter are preferably treated with surgery. This study aims to describe the use of radioiodine in a retrosternal goiter.

Methods

A 63-year-old female patient, a retired health worker, had been on antithyroid medication for over 20 years and referred for radioiodine therapy. Patient had developed a stroke from atrial fibrillation that occurred from the hyperthyroid state. Patient had thyroid scintigraphy with 74 MBq of [ 99m Tc] pertechnetate to assess the suitability and determine the dose of radioiodine. No anterior neck mass was visible on the patient.

Results

The thyroid scan showed intense uniform increased tracer accumulation in the thyroid bed which was continuous uniform uptake below the sternal notch extending well into the thorax. This was an enlarged retrosternal thyroid gland and because of patients fear for surgery and the comorbid conditions patient was treated with 1,110 MBq of iodine. Patient was still hyperthyroid at 6 months after treatment although the requirement for carbimazole had reduced from 40 mg a day to 10 mg a day. Patient was administered with a radioiodine [ 131 I] iodide and is currently euthyroid.

Discussion

Patient had been on an antithyroid drug for over 20 years with no visibly enlarged goiter. When the medical treatment was failing patient was asked to consider surgery but refused on the basis that the was no active gland. Patient was asked to consider radioiodine but refused due to unfounded fear on the use of iodine. Unfortunately, she developed complication and reluctantly came to the department. During the counselling for radioiodine patient had allot of misconceptions about radioiodine treatment which was corrected and not only did she get one but a repeat dose that rendered her euthyroid.

Conclusion

Patients with enlarged toxic goiter preferably have surgery for the treatment of their iodine, in that setting however, radioiodine may be used to control hyperthyroidism before surgery or even achieve a cure when surgery is not performed. Publication History Article published online: 25 May 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Zitieren

APA

Yartey, M. N., & Ankrah, A. O. (2023). Toxic Retrosternal Goiter Treated with Radioiodine: A Case Report. World Journal of Nuclear Medicine, 22(02), 152-170. https://doi.org/10.1055/s-0043-1769986

Vancouver

Yartey MN, Ankrah AO. Toxic Retrosternal Goiter Treated with Radioiodine: A Case Report. World Journal of Nuclear Medicine. 2023;22(02):152-170. doi:10.1055/s-0043-1769986

BibTeX
@article{Yartey2023,
  author = {Yartey, Miriam N.Y. and Ankrah, Alfred O.},
  title = {Toxic Retrosternal Goiter Treated with Radioiodine: A Case Report},
  journal = {World Journal of Nuclear Medicine},
  year = {2023},
  volume = {22},
  number = {02},
  pages = {152--170},
  doi = {10.1055/s-0043-1769986}
}
Kostenlos starten →